Collaborative Capital. Accelerating Growth. Advancing Care.

Our strategic pillars

Champion under appreciated healthcare founders at key company inflection points

Provide catalytic capital & strategic partnership
to unlock growth

Offer equity solutions optimized for asymmetric outcomes

Drive value creation through deep healthcare experience & ecosystem fluency

About us

Arcventis Health Partners is an investment firm focused on healthcare growth equity and growth buyout strategies committed to being a value-added partner to founders and management teams.

At Arcventis, we are bringing 25 years of collaboration, deep and complementary healthcare expertise and a shared conviction on investing and partnership, with the goal of creating category-defining market leaders in healthcare that benefit all key stakeholders: the patient, provider and payor.

“Arc” reflects the upward trajectory we help companies achieve, while “Ventis” conveys the momentum and energy we bring to every partnership.

Arcventis is Bold. Forward-moving and Purpose-driven. Focused on accelerating the Company through its arc of growth.

Where we invest

We offer equity solutions to achieve attractive target returns with an equal focus on minimizing losses while seeking alignment with founders and management teams.
- Significant Minority to Majority ownership
- Primary and Secondary
- Lead or Co-Lead
- Organic and Inorganic Growth
We invest in themes developed over close to 25 years of experience in healthcare to drive positive outcomes for all key stakeholders in the following key areas:
- Healthcare Information Technology
- Digital Health
- Medical Products including therapeutics, devices, diagnostics, and relevant supporting services
- Healthcare Infrastructure and Supporting Services
We partner with companies that have a capital-efficient strategy, proven commercial traction with established strategic, validating partnerships, strong barriers to entry and clear ROI
- At least $15m in revenue
- Breakeven within 12 months or already profitable
- Seeking $10-30m of capital as last round of financing prior to exit